Latest Share Purchase Plans News

QuickFee Limited has completed a significant A$118 million debt refinancing and successfully raised A$1.25 million through a share placement, alongside announcing a new Share Purchase Plan to support its expansion in the US and Australian markets.

Pacific Edge has successfully raised NZ$16 million through an upsized equity placement, surpassing its initial target and setting the stage for a planned NZ$5 million Share Purchase Plan. The funds aim to accelerate clinical and commercial milestones, including regaining Medicare coverage for its cancer diagnostic tests.

ALS Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to A$30,000 in new shares at a discounted price, following a recent $350 million institutional placement.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

TruScreen Group Limited has successfully raised NZ$2.35 million through a share placement, attracting new institutional investors from Asia, while launching a discounted share purchase plan for existing shareholders.

Aguia Resources Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a discount, aiming to raise up to $3 million to advance its phosphate and gold exploration projects.

American West Metals has launched a $1 million Share Purchase Plan following a $5.9 million placement, offering shareholders a discounted opportunity to invest in its Storm Project exploration activities.

Findi Ltd reports flat revenue and a 15% rise in EBITDA but swings to a $12.5 million net loss for FY2025, driven by strategic capital raises and refinancing in its Indian subsidiary.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Iltani Resources has launched a $1 million Share Purchase Plan (SPP) offering existing Australian and New Zealand shareholders the chance to buy shares at a 10.4% discount following a recent $1.8 million placement. The funds will support exploration at the Orient Project and general working capital.

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.